Navitas Life Sciences

Moving Ahead with Intelligent Virtual Clinical Trials

Fuelled by the current COVID-19 pandemic and the considerable volume of data generated during a clinical trial, Artificial Intelligence (AI) has provided the much-needed impetus for transforming clinical trials into the virtual sphere for greater efficiency. From patient recruitment, protocol design, trial monitoring, to identifying the effect of blood thinners on virtual patients with irregular heartbeats, leveraging AI has helped life-saving drugs reach the market sooner.

To download and read our article, authored by Dr. Ayaaz Hussain Khan, Global Head of Generics, and published in PharmaFocus Asia, please complete the adjacent form.

Article published in PharmaFocus Asia | Issue 41 | 2020

Pharma Focus Asia

Please complete form to download PDF
First Name
Last Name
Business Email
Job Title
By submitting this form, I agree to receive email communications from Navitas Life Sciences. Privacy Policy | EU-US & Swiss-US Privacy Shield Policy

© 2020 Navitas Life Sciences | Privacy Policy